NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00518895,Trial of Dacarbazine With or Without Genasense in Advanced Melanoma,https://clinicaltrials.gov/study/NCT00518895,AGENDA,COMPLETED,This study is being performed to prospectively determine whether dacarbazine plus Genasense is significantly better than dacarbazine plus placebo in chemotherapy-naive patients with advanced melanoma and low baseline LDH (LDH less than or equal to 0.8 times the upper limit of normal). LDH is a biomarker strongly associated with improved outcomes in a recent trial of dacarbazine plus Genasense.,NO,Melanoma,DRUG: dacarbazine plus Genasense|DRUG: dacarbazine plus placebo,"Progression-free survival and overall survival, Every 42 days from date of randomization during protocol therapy","Response rate, durable response rate, duration of response, safety, Response and progression every 42 days from date of randomization during protocol therapy",,Genta Incorporated,,ALL,"ADULT, OLDER_ADULT",PHASE3,300,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",AGENDA|GM307,2007-07,2011-05,2011-05,2007-08-21,,2011-11-06,"University of South Alabama Hospital, Mitchell Cancer Institute, Mobile, Alabama, 36607, United States|San Diego Pacific Oncology and Hematology Associates Inc., Encinitas, California, 92024, United States|Redwood Regional Medical Group, Inc., Santa Rosa, California, 95403, United States|Siouxland Hematology Oncology Associates, Sioux City, Iowa, 51101, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Hematology Oncology Centers of the Northern Rockies, Billings, Montana, 59101, United States|Morristown Memorial - Atlantic Healthcare System, Morristown, New Jersey, 07960, United States|Cancer Care Associates, Oklahoma City, Oklahoma, 73112, United States|Cancer Care Associates, Site 1, Tulsa, Oklahoma, 74104, United States|St. Luke's Cancer Center, Bethlehem, Pennsylvania, 18015, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, 19107, United States|The West Clinic, Memphis, Tennessee, 38120, United States|Texas Oncology - Sammons Cancer Center, Dallas, Texas, 75246, United States|MD Anderson Cancer Center at University of Texas, Houston, Texas, 77030-4009, United States|Sydney Cancer Center, Royal Prince Alfred Hospital, Camperdown, New South Wales, 2050, Australia|Calvary Mater Newcastle, Newcastle, New South Wales, Australia|Westmead Hospital, Westmead, New South Wales, Australia|Universitatsklinik fur Dermatologie und Venerologie, Medizinische Universitat Innsbruck, Innsbruck, Austria|Landesklinikum St. Polten, St. Polten, Austria|Medical University of Vienna, Vienna General Hospital, Wien, Austria|London Regional Cancer Program, London, Ontario, Canada|Princess Margaret Hospital, Toronto, Ontario, Canada|Charles University, Dermatology Department, Prague, Czech Republic|CHU Saint Jacques, Besancon, France|Hopital Saint-Andre, Bordeaux, France|CHU Ambroise Pare, Boulogne-Billancourt, France|CHU Hotel Dieu, Clermont Ferrand, France|CHU de Dijon, Hopital du Bocage Sud, Dijon, France|CHU de Grenoble, Hopital Albert Michallon, Grenoble, France|Centre Hospitalier du Mans, Le Mans, France|CHRU de Lille, Hopital Claude Huriez, Lille, France|Hopital de l'Hotel Dieu, Lyon, France|Hopital Sainte Marguerite, Marseille, France|Hopital Saint Eloi, Montpellier, France|CHU Hotel Dieu, Nantes, France|Hopital Saint-Louis, Paris, France|Hopital Robert Debre, Reims, France|CHU CH Nicolle, Rouen, France|Institut Gustave Roussy, Villejuif, France|Charite Universitatsmedizin Berlin, Berlin, Germany|Vivantes Klinikum im Friedrichshain, Berlin, Germany|Vivantes Klinikum Neukoln, Klinik fur Dermatologie und Venerologie, Berlin, Germany|Klinik fur Dermatologie und Allergologie der Ruhr-Universitat Bochum, Bochum, Germany|Helios Klinikum Erfurt, Erfurt, Germany|Klinik fur Dermatologie, Allergologie und Venerologie, Universitatsklinikum Essen, Essen, Germany|Universitatsklinikum Freiburg, Freiburg, Germany|Hautklinik Linden, Hannover, Germany|Klinikum der Friedrich-Schiller-Universitat Jena, Jena, Germany|Klinik und Poliklinik fur Dermatologie und Venerologie, Koln, Germany|Universitatklinikum A. o. R., Leipzig, Germany|Hospital of the University of Schleswig-Holstein, Lubeck, Germany|Universitats-Hautklinik Mainz, Mainz, Germany|Universitatsklinikum Mannheim, Mannheim, Germany|Universitatsklinikum Giessen und Marburg GmbH, Klinik fur Dermatologie und Allergologie, Marburg, Germany|Klinik und Poliklinik fur Hautkrankheiten, Munster, Germany|Helios Vogtland-Klinikum Plauen, Plauen, Germany|Klinikum Quedlinburg, Quedlinburg, Germany|Dermatologische Klinik und Poliklinik, Regensburg, Germany|Hautklinik Universitat Tubingen, Tubingen, Germany|Ospedale San Salvatore, Coppitto-L'Aquila, Italy|Istituto Nazionale dei Tumori, Milano, Italy|Istituto Nazionale dei Tumori ""G. Pascale"", Napoli, Italy|IFO Instituto Regina-Elena - IRCCS, Rome, Italy|Istituto Dermopatico dell'Immacolata, Rome, Italy|Azienda Ospedaliera Universitaria di Siena, Siena, Italy|Szpital Akademii Medycznej w Gdansku, Gdansk, Poland|Wielkopolskie Centrum Onkologii, Poznan, Poland|Hospital Clinic I Provincial de Barcelona, Barcelona, Spain|Hospital Germans Trias I Pujol, Barcelona, Spain|Hospital Gregorio Maranon, Madrid, Spain|Clinica Universitaria de Navarra, Navarra, Spain|University Hospital Zurich, Zurich, Switzerland|Guy's Hospital, London, United Kingdom|The Royal Marsden Hospital, London, United Kingdom|Christie Hospital, Manchester, United Kingdom|Nottingham University Hospitals NHS Trust, City Campus, Nottingham, United Kingdom|Weston Park Hospital, Sheffield, United Kingdom",
